Title:
ANTIBODIES WHICH BIND HUMAN CXCR3
Document Type and Number:
WIPO Patent Application WO2005030793
Kind Code:
A3
Abstract:
Antibodies and antigen-binding fragments of antibodies that bind human CXCR3 are disclosed. In preferred embodiments, the antibodies are human. Nucleic acids and vectors encoding the antibodies or portions thereof, recombinant cells that contain the nucleic acids, and compositions comprising the antibodies or antigen-binding fragments are also disclosed. The invention also provides therapeutic and diagnostic methods which employ the antibodies and antigen-binding fragments.
Inventors:
QIN SHIXIN (US)
KASSAM NASIM (US)
NEWMAN WALTER (US)
KASSAM NASIM (US)
NEWMAN WALTER (US)
Application Number:
PCT/US2004/031445
Publication Date:
January 05, 2006
Filing Date:
September 24, 2004
Export Citation:
Assignee:
MILLENNIUM PHARM INC (US)
QIN SHIXIN (US)
KASSAM NASIM (US)
NEWMAN WALTER (US)
QIN SHIXIN (US)
KASSAM NASIM (US)
NEWMAN WALTER (US)
International Classes:
A61K39/395; C07H21/04; C07K16/28; C12N5/06; C07K; (IPC1-7): A61K39/395
Foreign References:
| US6184358B1 | 2001-02-06 |
Other References:
See also references of EP 1631315A4
Download PDF:
Previous Patent: QUINOLINE POTASSIUM CHANNEL INHIBITORS
Next Patent: HEMIASTERLIN DERIVATIVES AND USES THEREOF
Next Patent: HEMIASTERLIN DERIVATIVES AND USES THEREOF